Press release
Unique treatment for erectile dysfunction and retrograde ejaculation due to BPH and prostatitis, COVID-19 protected, reveals Fine Treatment
Treatment with drugs and surgeries of enlarged prostate or benign prostatic hyperplasia (BPH) and chronic prostatitis /chronic pelvic pain syndrome (CP/CPPS) causes sexual dysfunction with the devastating symptom, such as erectile dysfunction, retrograde ejaculation and loss of libido. The only natural therapy with Dr Allen's Device has been working very well for men with BPH and chronic prostatitis during the last decade without side effects.Men with BPH and CP/CPPS can use Dr Allen's device at home, without visits clinics and hospitals therefore minimizing risk of getting COVID-19 from anyone. As COVID-19 - coronavirus spreads from person to person, visiting hospitals or clinics is an undesirable hazard for men and for medical personal.
Many scientific articles are emphasising a risk between BPH drugs and surgeries and development of sexual dysfunction. For instance, Dominique in the recent article: 'Benign prostatic hyperplasia surgery and patient's information: What do patients understand and remember?' states that information given before a BPH surgery about complications is poorly understood. Given the serious complications, a written information sheet is important for a good relationship between doctor and patient and judicial peace.
Treatment of BPH and CP/CPPS can cause new sexual problems
The most common medications for men with BPH and CP/CPPS are alpha-blockers (Flomax - tamsulosin, terazosin, etc.) that can cause for retrograde ejaculation, sexual dysfunction, headache, tiredness, dizziness, problems with the bladder and even dementia. However, alpha-blockers become ineffective in a couple of years.
Therefore, another common hormonal drug, 5alpha reductase inhibitors: finasteride, Avodart are prescribed. This causes more serious irreversible side effects: impotence, depression, testicle pain, cancer and even diabetes. However, due to problems with 5-alpha reductase inhibitors, its combination with alpha-blockers is often offered.
Thus, BPH drugs are harmful. Therefore, all medications to treat prostate enlargement should be used carefully and as a short-term treatment. Furthermore, the daily use of these dangerous drugs in a long-term is very expensive.
Surgical interventions in men with BPH remove or destroy prostate tissue. All of them have unpleasant complications. As a result, approximately 25% of patients after minimally invasive surgery suffer from depression. An article 'Retrograde ejaculation-a commonly unspoken aspect of prostatectomy for BPH, 2020, underlines that it is important for practicing family physicians and urologists to present retrograde ejaculation as a serious adverse effect and not to trivialize it.
Dr Allen's Device is unique treating BPH and prostatitis effectively and safe
Dr Allen's Device is a class 1 medical device. Therefore, it does not require the involvement of a notified body. The device is registered with Medical Healthcare Regulatory Agency from 2010. This means that every man with BPH and chronic pelvic pain can use it day and night without worrying, since is safe.
Thermobalancing therapy with Dr Allen's Device was patented by the USPTO. Fine Treatment https://finetreatment.com/ is a healthcare company, a manufacturer and distributor of wearable therapeutic Dr Allen's Devices. The device is easy to use, it consists of a wearable belt that attaches a special natural thermoelement to the coccyx.
Clinical controlled studies on Thermobalancing therapy were conducted in 124 men with BPH and 45 men with CP/CPPS and confirmed the effectiveness and safety of Dr Allen's device. Chronic pelvic pain and other unpleasant symptoms disappear within a few days or weeks, gradually improving symptoms of sexual dysfunction. Many scientific articles were published, https://finetreatment.com/thermobalancing-therapy-medical-scientific-data/.
Company Name: Fine Treatment
Contact Person: Dr Simon Allen, MD, PhD
Email: info@finetreatment.com
Phone: +447958878300
Country: United Kingdom
Website: https://finetreatment.com/
The use of Dr Allen's device reduces enlargement and inflammation of the prostate at home, naturally. Therefore, this therapy helps aging men with BPH and CP/CPPS avoid visits clinics and hospitals minimizing risks of getting coronavirus - COVID-19.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Unique treatment for erectile dysfunction and retrograde ejaculation due to BPH and prostatitis, COVID-19 protected, reveals Fine Treatment here
News-ID: 1992259 • Views: …
More Releases from Fine Treatment

Fine Treatment offers safe non-invasive device to dissolve stones in both kidney …
Kidney stone disease is a chronic condition as kidney stones grow constantly. Therefore, the treatment of kidney stones or renal calculi should be safe in the first place.
Innovative therapy that uses Dr Allen's device has worked well and safely for people with kidney stone disease over the past decade. This is the main reason for using it as a first line of treatment for dissolving kidney stones.
Recently, a new…

Lower urinary tract symptoms treatment with Dr Allen’s Device improves quality …
In a man, symptoms of lower urinary tract (LUTS), such as problems with urination, the need to urinate, frequent urination usually begin after 50 years due to an enlarged prostate, namely benign prostatic hyperplasia (BPH). An enlarged prostate gland irritates the bladder, causing a slowdown or even stopping of the outflow of urine from the bladder through the urethra.
BPH occurs in 50% of men older than 50 years, and this…
More Releases for BPH
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
BPH Surgical Treatment Market worth $17.19 billion in 2030
Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on "BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030
The global [https://www.marketsandmarkets.com/Market-Reports/benign-prostatic-hyperplasia-treatment-market-198000374.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=benignprostatichyperplasiasurgicaltreatmentmarket], valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in…
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
Benign Prostatic Hyperplasia (BPH) Treatment Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Benign Prostatic Hyperplasia (BPH) Treatment Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The benign prostatic hyperplasia (BPH) treatment market is experiencing significant growth due to the rising prevalence of BPH among the aging male…
How big is Benign Prostate Hyperplasia (BPH) Market?
Benign Prostate Hyperplasia (BPH) Market is forecasted to reach at a CAGR of 6% during the forecast period (2024-2031).
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Benign Prostate Hyperplasia (BPH) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market…
Laser BPH Devices Market Expected to Reach $765.4 Million by 2031
Laser BPH devices market was valued at $460.25 million in 2021, and is estimated to reach $765.4 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. Prostate enlargement, commonly known as benign prostatic hyperplasia (BPH), is a noncancerous expansion of the prostate gland. Frequent urination, difficulty starting to urinate, a weak stream, the inability to urinate, or a loss of bladder control are examples of symptoms.…